Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence? Chase R. Brown, MD, Fabliha.

Slides:

Advertisements

Similar presentations

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Advertisements

Manuel J. Antunes, MD, PhD, DSc

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Stephen R. Broderick, MD, MPHS

A hybrid configuration of a left ventricular assist device and venovenous extracorporeal membrane oxygenation Louis Samuels, MD, Eric Gnall, DO, Elena.

Long-term mechanical circulatory support: A new disease state?

Moderate mitral regurgitation in aortic root replacement surgery: Comparing mitral repair with no mitral repair Fenton H. McCarthy, MD, Nimesh D. Desai,

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

Shinichi Fukuhara, MD, Koji Takeda, MD, PhD, Paul A

Stenting of an outflow graft obstruction after implantation of a continuous-flow, axial-flow left ventricular assist device Duc Thinh Pham, MD, Navin.

Association of device surface and biomaterials with immunologic sensitization after mechanical support Isaac George, MD, Patrick Colley, BS, Mark J.

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant Victor van Berkel, MD, PhD

New anticoagulant coatings and hemostasis assessment tools to avoid complications with pediatric left ventricular assist devices Daniel C. Leslie, PhD,

Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices Ranjit John, MD, Kenneth Liao,

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Elucidating the intricate mechanisms of gastrointestinal bleeding in a continuous-flow left ventricular assist device will lead to future therapeutic.

Form ever follows function

William M. DeCampli, MD, PhD

Outcomes of contemporary mechanical circulatory support device configurations in patients with severe biventricular failure Allison P. Levin, BA, MSc,

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes

Intra-aortic balloon pump therapy negatively affects flow through a continuous-flow left ventricular assist device Dipanjan Banerjee, MD, MS, Chun Choi,

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

A technique for implanting outflow cannulas for Berlin Heart EXCOR ventricular assist device in small pediatric patients Khanh Nguyen, MD The Journal.

Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology Juan A. Crestanello, MD The Journal of.

Intra-aortic balloon pumps and continuous flow left ventricular assist devices: Don't let balloon pumps overstay their welcome Kevin G. Soucy, PhD, Steven.

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Nationwide cohort study of mitral valve repair versus replacement for infective endocarditis Hsiu-An Lee, MD, Yu-Ting Cheng, MD, Victor Chien-Chia Wu,

Left ventricular assist device therapy in a patient with hearing and speech disabilities Sotirios Spiliopoulos, MD, PhD, Vera Hergesell, MD, Otto Dapunt,

Abdul Rahman Dakkak, MD, Angelo M. Dell'Aquila, MD, Juergen R

Innovation and science: The future of valve design

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

The American Association for Thoracic Surgery Ethics Forum: How should a surgeon respond to a patient's request to hasten death? Kathleen N. Fenton,

A first start for lung transplantation?

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

Stephen R. Broderick, MD, MPHS

Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011 William L.

William L. Holman, MD, James K. Kirklin, MD, David C

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

The Ross procedure: Time to reevaluate the guidelines

The use of mechanical circulatory support as a bridge to transplantation in pediatric patients: An analysis of the United Network for Organ Sharing database

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Jay K. Bhama, MD, Utsav Bansal, BS, Daniel G. Winger, MS, Jeffrey J

Shunt right or left? Decision 2016

Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: A two-center study Nicholas C. Dang,

Lower-extremity complications with femoral extracorporeal life support

Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant.

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk? Mathew Williams, MD, Jennifer Casher,

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices Forum Kamdar, MD, Ranjit John,

The continuing challenge of congenital heart disease in China

Cerebrovascular accidents in patients with a ventricular assist device

Optimal timing of cardiac transplantation after ventricular assist device implantation James S Gammie, MD, Leah B Edwards, PhD, Bartley P Griffith, MD,

Seeing is believing: A call for routine early postoperative hemodynamic transesophageal echocardiography monitoring after left ventricular assist device.

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Daisuke Yoshioka, MD, Hiroo Takayama, MD, Arthur R. Garan, MD, Veli K

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Gastrointestinal bleeding after left ventricular assist device implantation: It is all about the platelets Juan A. Crestanello, MD The Journal of Thoracic.

Hari R. Mallidi, MD The Journal of Thoracic and Cardiovascular Surgery

Presentation transcript:

Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence? Chase R. Brown, MD, Fabliha Khurshan, BA, Zehang Chen, BA, BSN, Peter W. Groeneveld, MD, Fenton McCarthy, MD, MS, Michael Acker, MD, J. Eduardo Rame, MD, Nimesh Desai, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 157, Issue 6, Pages 2315-2324.e4 (June 2019) DOI: 10.1016/j.jtcvs.2018.12.118 Copyright © 2019 Terms and Conditions

Figure 1 Flow chart of patient inclusion and exclusion criteria. BTT, Bridged to transplant; LVAD, left ventricular assist device. The Journal of Thoracic and Cardiovascular Surgery 2019 157, 2315-2324.e4DOI: (10.1016/j.jtcvs.2018.12.118) Copyright © 2019 Terms and Conditions

Figure 2 Survival after heart transplantation based on bridge to transplant (BTT) duration with a left ventricular assist device. The 95% confidence intervals for survival can be found in Table E1. The Journal of Thoracic and Cardiovascular Surgery 2019 157, 2315-2324.e4DOI: (10.1016/j.jtcvs.2018.12.118) Copyright © 2019 Terms and Conditions

Figure 3 Hazard ratio for mortality after heart transplantation based on bridge to transplant duration with a left ventricular assist device (LVAD). The Journal of Thoracic and Cardiovascular Surgery 2019 157, 2315-2324.e4DOI: (10.1016/j.jtcvs.2018.12.118) Copyright © 2019 Terms and Conditions

Figure E1 A histogram of patients bridged to transplant with a left ventricular assist device. The Journal of Thoracic and Cardiovascular Surgery 2019 157, 2315-2324.e4DOI: (10.1016/j.jtcvs.2018.12.118) Copyright © 2019 Terms and Conditions

Risk of death after heart transplant based on bridge to transplant duration with an LVAD. The Journal of Thoracic and Cardiovascular Surgery 2019 157, 2315-2324.e4DOI: (10.1016/j.jtcvs.2018.12.118) Copyright © 2019 Terms and Conditions

The Journal of Thoracic and Cardiovascular Surgery 2019 157, 2315-2324 The Journal of Thoracic and Cardiovascular Surgery 2019 157, 2315-2324.e4DOI: (10.1016/j.jtcvs.2018.12.118) Copyright © 2019 Terms and Conditions